MCI Stock Overview
Medcaw Investments Plc intends to undertake an acquisition or acquisitions in the life sciences sector focusing on companies developing medical or wellness technologies and therapies.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Medcaw Investments Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.04 |
| 52 Week High | UK£0.08 |
| 52 Week Low | UK£0.02 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -61.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| MCI | GB Capital Markets | GB Market | |
|---|---|---|---|
| 7D | 0% | 0.4% | 2.7% |
| 1Y | n/a | 7.4% | 0.3% |
Return vs Industry: Insufficient data to determine how MCI performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how MCI performed against the UK Market.
Price Volatility
| MCI volatility | |
|---|---|
| MCI Average Weekly Movement | n/a |
| Capital Markets Industry Average Movement | 4.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.3% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: MCI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MCI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2020 | 3 | n/a | medcaw-invest.com |
Medcaw Investments Plc intends to undertake an acquisition or acquisitions in the life sciences sector focusing on companies developing medical or wellness technologies and therapies. The company was incorporated in 2020 and is based in London, the United Kingdom.
Medcaw Investments Plc Fundamentals Summary
| MCI fundamental statistics | |
|---|---|
| Market cap | UK£885.28k |
| Earnings (TTM) | -UK£194.01k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-4.6x
P/E RatioIs MCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MCI income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£194.01k |
| Earnings | -UK£194.01k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0088 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did MCI perform over the long term?
See historical performance and comparison